NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test) |
|||
UNCOV-40 | Atlas Link Technology | 40 Tests | EUR 115 |
Human IgG antibody Laboratories manufactures the sars-co2 antibody test reagents distributed by Genprice. The Sars-Co2 Antibody Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Sars-Co2 products are available in stock. Specificity: Sars-Co2 Category: Antibody Group: Test
EM (Anti-endometrial Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of EM (Anti-endometrial Antibody IgG) |
ASA (Anti-sperm Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of ASA (Anti-sperm Antibody IgG) |
Mg (Mycoplasma Genitalium Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of Mg (Mycoplasma Genitalium Antibody IgG) |
Mh (Mycoplasma Hominis Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of Mh (Mycoplasma Hominis Antibody IgG) |
Ct (Chlamydia Trachomatis Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of Ct (Chlamydia Trachomatis Antibody IgG) |
MV (Measles Virus Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of MV (Measles Virus Antibody IgG) |
TB (Mycobacterium Tuberculosis Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of TB (Mycobacterium Tuberculosis Antibody IgG) |
SARS Spike Antibody |
|||
24218-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
24219-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
24318-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
20-abx137184 | Abbexa |
|
|
SARS Spike Antibody |
|||
20-abx137200 | Abbexa |
|
|
SARS Matrix Antibody |
|||
24319-100ul | SAB | 100ul | EUR 468 |
SARS Matrix Antibody |
|||
24320-100ul | SAB | 100ul | EUR 468 |
SARS Envelope Antibody |
|||
24321-100ul | SAB | 100ul | EUR 468 |
SARS Envelope Antibody |
|||
24322-100ul | SAB | 100ul | EUR 468 |
GENLISA™ SARS-CoV-2 (Covid-19) Surrogate Virus Neutralization Test (sVNT) ELISA |
|||
KBVH400 | Krishgen | 12 × 8 wells | EUR 3822 |
PLPro Antibody (SARS-CoV) |
|||
100863 | BPS Bioscience | 250 µg | EUR 360 |
Description: Chicken polyclonal antibody recognizing the SARS-CoV Papain-like Protease (PLpro) as a 35 kDa protein. Purified from egg yolks. This antibody recognizes PLPro from both SARS-CoV-1 and SARS-CoV-2. Does not cross react with SARS-CoV 3CL protease. |
SARS-CoV Spike Antibody |
|||
3225-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3225-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3219-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3219-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3221-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3221-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |